NCT02145910 2025-05-02
Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
Thomas Jefferson University
Phase 1 Withdrawn
Clinical Trials
12 trialsNCT05900908 2025-04-10
PATHWAyS
GT Medical Technologies, Inc.
Phase 4 Withdrawn
NCT03956706 2023-03-15
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
Northwell Health
Phase NA Withdrawn
NCT04650490 2023-03-02
STICk-IM-NSCLC
Duke University
Phase 2 Withdrawn
NCT04069910 2022-01-31
Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases
Jonsson Comprehensive Cancer Center
Phase NA Withdrawn
NCT02567643 2022-01-11
Stereotactic Radiosurgery (SRS) for Multiple CNS Mets
The Cooper Health System
Phase NA Withdrawn
NCT02277561 2020-03-04
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
Albert Einstein College of Medicine
Phase NA Withdrawn
NCT01731704 2017-03-14
NAGKC 12-01
University of California, San Francisco
Phase NA Withdrawn
NCT01169129 2014-02-04
Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases
Barretos Cancer Hospital
Phase 3 Withdrawn
NCT00385398 2013-09-02
QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC
Rutgers, The State University of New Jersey
Phase 2 Withdrawn
NCT01295970 2013-06-13
Surgery Versus Radiosurgery for the Treatment of Single Brain Metastases
University Health Network, Toronto
Phase NA Withdrawn
NCT00738335 2012-10-04
Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases
University of California, San Francisco
Phase 1 Withdrawn